Department of Neurology, Ospedale degli Infermi, Rimini, Italy.
Department of Neurology, Niguarda Ca' Granda Hospital, Milan, Italy.
Acta Neurol Scand. 2021 May;143(5):554-557. doi: 10.1111/ane.13390. Epub 2021 Feb 1.
Mechanical thrombectomy (MT) is effective in treating ischemic strokes due to large vessel occlusion. However, the risk-benefit ratio of intravenous thrombolysis (IVT) prior to MT is still unclear. Aim of the study was to provide a pooled analysis of only randomized controlled trials (RCTs) comparing direct MT (dMT) vs bridging treatment (IVT+MT).
PubMed, EMBASE and Cochrane Central were searched only for RCTs comparing IVT+MT vs dMT in ischemic stroke patients. Primary endpoint was functional independence at 90 days (mRS<3), while secondary endpoints were represented by successful recanalization (TICI>2a), mortality at 90 days and symptomatic intracranial hemorrhage (sICH). Odds ratios for endpoints were pooled with meta-analysis and compared between reperfusion strategies.
The pooled analysis comprised 5 studies (n. patients = 1657). The rates for the primary endpoint were 39% and 34.5% for dMT and IVT+MT, respectively (OR 1.06; 95%CI 0.80-1.40). For the secondary endpoints, we did not observe significant differences between groups, even if the rate of successful recanalization was higher in IVT+MT treated patients (OR: 0.58; 95%CI 0.26-1.30;p = 0.002), without a significant increase in sICH rates (4.3% vs 5.5%; OR: 0.96; 95%CI 0.43-2.13;p = 0.26). Finally, mortality rates were 19.8% and 15.9% for dMT and IVT+MT, respectively.
In this meta-analysis including only RCTs, dMT and bridging treatment were substantially equivalent for good functional outcome. IVT+MT was associated to higher rates of successful recanalization, even if not significant. Therefore, further adequately powered RCTs comparing dMT vs IVT+MT are warranted.
机械血栓切除术(MT)在治疗因大血管闭塞引起的缺血性中风方面是有效的。然而,静脉溶栓(IVT)在先与 MT 联合应用的风险效益比仍不清楚。本研究的目的是对仅比较直接 MT(dMT)与桥接治疗(IVT+MT)的随机对照试验(RCT)进行汇总分析。
仅在 PubMed、EMBASE 和 Cochrane Central 中检索比较缺血性脑卒中患者 IVT+MT 与 dMT 的 RCT。主要终点为 90 天(mRS<3)时的功能独立性,次要终点为成功再通(TICI>2a)、90 天死亡率和症状性颅内出血(sICH)。使用荟萃分析汇总终点的优势比,并比较再灌注策略之间的差异。
该汇总分析纳入了 5 项研究(n.患者=1657)。dMT 和 IVT+MT 的主要终点发生率分别为 39%和 34.5%(OR 1.06;95%CI 0.80-1.40)。对于次要终点,我们没有观察到组间的显著差异,尽管 IVT+MT 治疗的患者再通成功率更高(OR:0.58;95%CI 0.26-1.30;p = 0.002),但 sICH 发生率没有显著增加(4.3%比 5.5%;OR:0.96;95%CI 0.43-2.13;p = 0.26)。最后,dMT 和 IVT+MT 的死亡率分别为 19.8%和 15.9%。
在本汇总分析中,仅包括 RCT,dMT 和桥接治疗在良好的功能结局方面基本相当。IVT+MT 与更高的再通成功率相关,尽管差异无统计学意义。因此,需要进一步进行比较 dMT 与 IVT+MT 的充分随机对照试验。